2020-06-11
Legal Press releases
Stockholm 11 June 2020 – The Swedish biotechnology company Intervacc AB (publ), which is developing modern, effective and safe vaccines for animal health has appointed Dr. Andrew Waller as the new Chief Scientific ... Read more
2020-06-04
Legal Press releases
Results and analyses from clinical trials on the Strangvac® vaccine research project have been published online in the leading scientific journal ‘Vaccine’. The article highlights that Strangvac® ... Read more
2020-03-26
Legal Press releases
Stockholm 25 March 2020 - Intervacc AB (publ) will continue the development of its new vaccine against Staphylococcus aureus infections that cause mastitis in dairy cows. The project will be co-financed by Intervacc and ... Read more
2020-03-18
Legal Press releases
Stockholm March 18, 2020 - Intervacc AB (publ) announces that the European Medicines Agency, EMA, has today confirmed that the company's application for the granting of a Community marketing authorization for Strangvac is ... Read more
2020-02-26
Legal Press releases
Stockholm February 26, 2020 - Intervacc AB (publ) announces that the Company’s Marketing Authorization Application (MAA) for review of Strangvac® has been submitted today to the European Medicines Agency ... Read more
2020-02-06
Legal Press releases